Co-Founder and CEO at Applied Dexterity.
Prior to co-founding Applied Dexterity, David Drajeske led Biotech BD, LLC, a consultancy providing strategy, business development, and licensing services to life science companies. Clients included companies focused on medical devices, drug development, drug delivery, bioprocessing and industrial biotech. David has helped a number of companies to refine and adapt their business models and achieve early revenue. He has guided technology platform providers in tailoring their systems to meet the needs of a wide range of collaborators. He has served in a Business Development role at companies ranging from a bootstrapped start-up in a technology incubator, through a VC backed clinical stage drug developer, and including large public technology and therapeutics companies. These companies include Amgen, Immunex, Koronis Pharmaceuticals, Helix BioMedix, ThermoGen, MediChem Life Sciences, and Motorola New Enterprises. David received an M.S. in Biotechnology from Northwestern University’s Kellogg Center for Biotechnology and a B.S. in Chemical Engineering from Purdue University.
Visit website: https://applieddexterity.com/about/team/
See also: Applied Dexterity - Driving Innovation in Surgical Robotics.
David Drajeske News
FDA approves new medical robot from Auris Surgical
IEEE Spectrum - 07-Jun-2016
Teleoperated ARES robot (Auris Robotic Endoscopy System) was cleared by the FDA at the end of May...Read more...